EMILY POMANTE: Open Payments
NPI 1497131114 · WAYNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 25 payments from 7 companies in 2025. Trend: 2023 $504 · 2024 $262 · 2025 $563
Food & beverage: $419Education: $144
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $143 |
| MILLICENT US INC | 6 | $136 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $126 |
| Exeltis, USA Inc. | 5 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| Organon LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: SLYND, FEMLYV, Veozah, Mirena, FEMRING, NEXPLANON, MYFEMBREE.
Industry payments across NJ — which companies pay providers there.
